Announcements
Spend $50 or more, get FREE SHIPPING automatically!
Top-Rated Cannabis Edible Marketplace
Best THC Gummies Online™
Instagram Twitter Youtube
A promotional banner with a dark background divided into three sections. On the left, there's a symbol of a shield with a privacy lock and the text 'YOUR PRIVACY, OUR PRIORITY.' The middle shows an illustration of a person in thought with a question mark and a secure box, with the phrase 'ALWAYS DISCREET SHIPPING.' The right section features the THCGummies.com logo, an artistically designed cannabis leaf within a white circle, alongside the assurance 'WITH EVERY PURCHASE.'

The Three Components Of The ECS

This scientific illustration visually highlights the essential parts of the ECS, with the title 'Three Key Components of the Endocannabinoid System.' Set against a microscopic cellular backdrop, it identifies an 'ENDOCANNABINOID,' illustrated as a purple sphere; a 'CANNABINOID RECEPTOR,' shown as a socket on the blue cell wall; and 'METABOLIC ENZYMES,' depicted as orange and yellow clusters engaging with the endocannabinoid. All key parts are prominently displayed, indicating the importance of these three components in the functioning of the ECS. This vivid visualization removes any confusion and is great for educational purposes.

The three lesser-known guardians of internal balance tirelessly toil in the shadows of our biology. These are the key parts of the Endocannabinoid System (ECS): ENDOCANNABINOIDS (messengers), CANNABINOID RECEPTORS (message receivers/deliverers), and METABOLIC ENZYMES (cannabinoid clean up crew).

The harmonious interplay of these three components give us profound insights into human health and homeostasis.

Table of Contents

EST. READING TIME: 6 Minutes
EST. READING TIME: 6 Minutes

POP QUIZ!

What are the three key parts that make up the Endocannabinoid System?

A) Anandamide, Lipid Proteins, Metabolic Enzymes
B) Neurotransmitters, Synapses, Cannabinoids
C) Endocannabinoids, Cannabinoid Receptors, Metabolic Enzymes
D) Endocannabinoids, CB1 Receptors, CB2 Receptors

Today, you’ll learn about the three main components of the Endocannabinoid System; covering the following four points for each:

  1. The scientific definition
  2. A detailed and more comprehensive explanation
  3. The roles & responsibilities
  4. The main types

Backed by tremendous research for every discussion point, you will find a supporting research study for verification.

#1. Endocannabinoids:

  • Scientific definition: Endocannabinoids are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors [1].
  • Comprehensive Explanation: Endocannabinoids are naturally occurring molecules produced by the body that activate the same receptors as the active components in cannabis (cannabinoids). They are part of a complex cell-signaling system known as the endocannabinoid system, which helps regulate various physiological processes [2].
An illustrative digital rendering portrays the interaction between an endocannabinoid and a receptor. In the foreground, a detailed cellular structure with a blue and white cell wall is depicted. A labeled arrow points to the wall indicating "cannabinoid receptor type 1, also known as cb1. " above this, a spherical entity with a lavender glow represents the endocannabinoid n-arachidonoylethanolamine, labeled "endocannabinoid, also known as anandamide (aea). " the deep space-like background with scattered light particles adds a cosmic feel to the image, emphasizing the significance of this microscopic interaction. A disclaimer at the bottom notes, "for illustration purposes not actual representations," reminding viewers of the artistic interpretation of the scientific concept. A cannabis leaf icon is subtly included, associating the image with cannabis research and science.

Roles and responsibilities:

  • Modulating neurotransmitter release [3]
  • Regulating pain, inflammation, and immune responses [4]
  • Influencing appetite, mood, and memory [5]
  • Maintaining homeostasis in the body [6]

Two Main Endocannabinoids In The ECS

The two main endocannabinoids are:

  1. anandamide (AEA)
  2. 2-arachidonoylglycerol (2-AG) [7].

#2 Cannabinoid Receptors:

  • Scientific definition: Cannabinoid receptors are G protein-coupled receptors that are activated by endocannabinoids and exogenous cannabinoids [8].
  • Comprehensive Explanation: Cannabinoid receptors are cell membrane receptors that bind to endocannabinoids and cannabinoids, triggering various cellular responses. They are found throughout the body, particularly in the central and peripheral nervous systems, as well as in immune cells [9].
This is a digital visualization depicting a segment of a neuron with a detailed focus on cannabinoid receptors. The image showcases the neuron in a vibrant blue tone with highlighted receptor sites that glow in a vivid orange, labeled as "cannabinoid receptors". The background is artistically blurred, featuring contrasting red and blue hues that create a dynamic and moody atmosphere.

Roles and responsibilities:

  • Mediating the effects of endocannabinoids and cannabinoids [10]
  • Regulating neurotransmission and synaptic plasticity [11]
  • Modulating pain perception, inflammation, and immune function [12]
  • Influencing appetite, mood, and memory [13]

Two Main Cannabinoid Receptors In The ECS

The two main types of cannabinoid receptors are CB1 and CB2 receptors [14].

#3. Metabolic Enzymes:

  • Scientific definition: Metabolic enzymes are proteins that catalyze the synthesis, transport, and degradation of endocannabinoids [15].
  • Comprehensive definition: Metabolic enzymes are responsible for the production, movement, and breakdown of endocannabinoids within the endocannabinoid system. They help maintain the balance of endocannabinoids in the body and ensure that they are available when needed and removed when their function is complete [16].
An illustrative digital rendering portrays metabolic enzymes interacting with endocannabinoids within the body. The composition is set against a dark backdrop that is reminiscent of the interior of a biological environment, highlighted with faint glimmers resembling cellular activity. Foregrounded are vibrant orange and yellow enzyme clusters with bulbous outgrowths, symbolizing their active sites as they latch onto spherical endocannabinoid molecules. Textual cues narrate the biochemical drama: "metabolic enzymes attach to an endocannabinoid to begin the metabolizing it," and a follow-up "further along the process; enzymes have covered the endocannabinoid & will soon completely eliminate it in order to restore balance. " the note at the bottom, "for illustration purposes not actual representations," serves as a reminder that this is an artistic conceptualization of a microscopic process.

Roles and responsibilities:

  • Synthesizing endocannabinoids from precursor molecules [17]
  • Transporting endocannabinoids to target receptors [18]
  • Degrading endocannabinoids to terminate their signaling [19]
  • Regulating the overall activity of the endocannabinoid system [20]

Four Main Metabolic Enzymes In The ECS

The main metabolic enzymes involved in the ECS are:

  • Fatty acid amide hydrolase (FAAH): Degrades anandamide [21]
  • Monoacylglycerol lipase (MAGL): Degrades 2-AG [22]
  • N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD): Synthesizes anandamide [23]
  • Diacylglycerol lipase (DAGL): Synthesizes 2-AG [24]

Summary & Final Thoughts

These three components work together to form the endocannabinoid system, which plays a crucial role in maintaining homeostasis and regulating various physiological processes in the body [25].

References

  1. Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual review of psychology, 64, 21-47. https://doi.org/10.1146/annurev-psych-113011-143739
  2. Lu, H. C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological psychiatry, 79(7), 516-525. https://doi.org/10.1016/j.biopsych.2015.07.028
  3. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiological reviews, 89(1), 309-380. https://doi.org/10.1152/physrev.00019.2008
  4. Witkamp, R. (2018). The endocannabinoid system and inflammation: potential for therapeutic intervention. Current Pharmaceutical Design, 24(21), 2413-2421. https://doi.org/10.2174/1381612824666180703161325
  5. Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual review of psychology, 64, 21-47. https://doi.org/10.1146/annurev-psych-113011-143739
  6. Di Marzo, V. (2018). New approaches and challenges to targeting the endocannabinoid system. Nature reviews Drug discovery, 17(9), 623-639. https://doi.org/10.1038/nrd.2018.115
  7. Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004). The endocannabinoid system and its therapeutic exploitation. Nature reviews Drug discovery, 3(9), 771-784. https://doi.org/10.1038/nrd1495
  8. Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin. British journal of pharmacology, 153(2), 199-215. https://doi.org/10.1038/sj.bjp.0707442
  9. Mackie, K. (2008). Cannabinoid receptors: where they are and what they do. Journal of neuroendocrinology, 20(s1), 10-14. https://doi.org/10.1111/j.1365-2826.2008.01671.x
  10. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., … & Pertwee, R. G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological reviews, 54(2), 161-202. https://doi.org/10.1124/pr.54.2.161
  11. Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012). Endocannabinoid signaling and synaptic function. Neuron, 76(1), 70-81. https://doi.org/10.1016/j.neuron.2012.09.020
  12. Pertwee, R. G. (2001). Cannabinoid receptors and pain. Progress in neurobiology, 63(5), 569-611. https://doi.org/10.1016/S0301-0082(00)00063-5
  13. Zanettini, C., Panlilio, L. V., Alicki, M., Goldberg, S. R., Haller, J., & Yasar, S. (2011). Effects of endocannabinoid system modulation on cognitive and emotional behavior. Frontiers in behavioral neuroscience, 5, 57. https://doi.org/10.3389/fnbeh.2011.00057
  14. Pertwee, R. G. (2006). The pharmacology of cannabinoid receptors and their ligands: an overview. International journal of obesity, 30(1), S13-S18. https://doi.org/10.1038/sj.ijo.0803272
  15. Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008). Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chemical reviews, 108(5), 1687-1707. https://doi.org/10.1021/cr0782067
  16. Fezza, F., Bari, M., Florio, R., Talamonti, E., Feole, M., & Maccarrone, M. (2014). Endocannabinoids, related compounds and their metabolic routes. Molecules, 19(11), 17078-17106. https://doi.org/10.3390/molecules191117078
  17. Tsuboi, K., Uyama, T., Okamoto, Y., & Ueda, N. (2018). Endocannabinoids and related N-acylethanolamines: biological activities and metabolism. Inflammation and regeneration, 38(1), 1-10. https://doi.org/10.1186/s41232-018-0086-5
  18. Chicca, A., Marazzi, J., Nicolussi, S., & Gertsch, J. (2012). Evidence for bidirectional endocannabinoid transport across cell membranes. Journal of Biological Chemistry, 287(41), 34660-34682. https://doi.org/10.1074/jbc.M112.374124
  19. Lodola, A., Castelli, R., Mor, M., & Rivara, S. (2015). Fatty acid amide hydrolase inhibitors: a patent review (2009-2014). Expert opinion on therapeutic patents, 25(11), 1247-1266. https://doi.org/10.1517/13543776.2015.1067683
  20. Savinainen, J. R., Saario, S. M., & Laitinen, J. T. (2012). The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2‐arachidonoylglycerol signalling through cannabinoid receptors. Acta physiologica, 204(2), 267-276. https://doi.org/10.1111/j.1748-1716.2011.02280.x
  21. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384(6604), 83-87. https://doi.org/10.1038/384083a0
  22. Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., … & Piomelli, D. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation.Proceedings of the National Academy of Sciences, 99(16), 10819-10824. https://doi.org/10.1073/pnas.152334899
  23. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004). Molecular characterization of a phospholipase D generating anandamide and its congeners. Journal of Biological Chemistry, 279(7), 5298-5305. https://doi.org/10.1074/jbc.M306642200
  24. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., … & Doherty, P. (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. The Journal of cell biology, 163(3), 463-468. https://doi.org/10.1083/jcb.200305129
  25. Lu, H. C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological psychiatry, 79(7), 516-525. https://doi.org/10.1016/j.biopsych.2015.07.028
The image shows a combination of elements that conveys the theme of enlightenment and knowledge in the realm of cannabis. The image with its vivid flame, the ripples, and the cannabis leaf, the glowing orb, along with the cannabis gummies, creates a striking visual metaphor. The slogan "Igniting Ripples of Cannabis Wisdom" with the title, 'THCGummies.com', and the trademark, 'Best THC Gummies Online™' complements the imagery with a powerful message.

If this article sparked a new insight, pass the flame…

LET’S IGNITE RIPPLES OF CANNABIS WISDOM.

Be the catalyst for someone’s breakthrough moment.

SHARE ON SOCIAL MEDIA

Leave a Reply

Your email address will not be published. Required fields are marked *

250x250px -- Christopher Visser, CEO of THCGummies.com and Cannabidiol Life, CoFounder of ChatCBD.com. He is wearing a 3-piece suit with a gradient dark background.
Christopher Visser
Christopher Visser, a prominent figure in the CBD industry, is the Founder and CEO of Cannabidiol Life and THCGummies.com, as well as the Co-Founder of ChatCBD.com. With experience spanning over several years, Chris has unintentionally proven to the world his love for cannabis. He further solidifies his stance in the industry through his unwavering dedication to advancing cannabis understanding and his relentless approach to research. In 2016, prior to the Farm Bill of 2018, Chris pioneered CannabidiolLife.com, which was considered the first CBD health-specific educational website. The site featured content supported by clinical and scientific research studies, covering 50 of the most common medical conditions where CBD had shown potential therapeutic value. Chris's efforts were recognized by the National Hemp Foundation in 2017, and CannabidiolLife.com served as their online source for "CBD Health Education & Product Guides" for a six-month period. Following the passage of the Farm Bill in 2018, Chris adapted to the changing landscape by transitioning CannabidiolLife.com to CBDOilsAndEdibles.com, focusing on providing the highest-quality CBD products to those who needed them most. The testimonials he received during this period had a profound impact on him, further fueling his passion for cannabis education and research. As a reputable cannabis researcher, blogger, and soon-to-be-author, Christopher Visser is set to release his first book, "The Cannabis Compendium: A Confluence That Goes Beyond the High," in mid-2025. His expertise is rooted in his fundamental belief in putting people first, his extensive analysis of countless cannabis studies, his collaboration with medical professionals, and his personal engagement with thousands of customers over the years. By 2024, Chris had built two thriving cannabis ventures, collectively generating millions in annual sales and expanding across five countries. His unique opportunity to work directly with cannabis consumers through his businesses brings a trustworthy, authoritative, and importantly, unique perspective to the cannabis industry – something that cannot be said often. Chris's dedication to advancing cannabis understanding through research, education, and personal interaction has solidified his position as a trusted expert in the industry.
View All Articles By Christopher Visser

YOUR CANNABIS EDIBLE
JOURNEY CONTINUES: 

Looking For Something Else?

Popular Keywords

Categories

Total Results

No Record Found

View All Results
THCGummies.com Logo with dimensions 250 pixels by 250 pixels. High definition image using 1200 DPI (Dots Per Inch).

AGE VERIFICATION

You must be 18 years old to access THCGummies.com (educational purposes) and 21 years or older to purchase.

PLEASE CONFIRM IF YOU MEET THESE REQUIREMENTS:

Yes, I'm Of Age.
No, I'm sorry.

WE NEVER SELL OR SHARE YOUR INFORMATION. By clicking “YES,” you agree to abide by all Terms of Use and consent to our use of cookies as outlined in our Privacy Policy.